PM

Preethi Muninarayanappa

Active Director Director DIN 11137902
DIN 11137902 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Preethi Muninarayanappa

Data last updated:

Preethi Muninarayanappa is a Director at Crinamed Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11137902
Primary Designation Director
Industry Pharma
First Appointment 03 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jun 20252025Active

Board colleagues of Preethi Muninarayanappa

Directorship timeline

Open interactive timeline →
Crinamed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Preethi Muninarayanappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preethi Muninarayanappa

Preethi Muninarayanappa currently holds 1 directorship: Crinamed Pharmaceuticals Private Limited (Director, since 03 Jun 2025).

Preethi Muninarayanappa was first appointed on 03 Jun 2025 as Director at Crinamed Pharmaceuticals Private Limited.

The current boards of Preethi Muninarayanappa's companies include Jaleel Nijamuddin (Crinamed Pharmaceuticals Private Limited), Jayanthi Doddi Ambrish (Crinamed Pharmaceuticals Private Limited), Kunchitiga Manjula (Crinamed Pharmaceuticals Private Limited), Nallabathini Krishnareddy (Crinamed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available